References

1. A.J. Ebele, M. Abou-Elwafa Abdallah, S. Harrad, Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment, Emerging Contam., 3 (2017) 1–16.
2. Y. Yang, Y.S. Ok, K.-H. Kim, E.E. Kwon, Y.F. Tsang, Occurrences and removal of pharmaceuticals and personal care products (PPCPs) in drinking water and water/sewage treatment plants: a review, Sci. Total Environ., 596–597 (2017) 303–320.
3. Q. Sui, X.Q. Cao, S.G. Lu, W.T. Zhao, Z.F. Qiu, G. Yu, Occurrence, sources and fate of pharmaceuticals and personal care products in the groundwater: a review, Emerging Contam., 1 (2015) 14–24.
4. W.C. Li, Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil, Environ. Pollut., 187 (2014) 193–201.
5. K. Styszko, U.E. Bollmann, K. Bester, Leaching of biocides from polymer renders under wet/dry cycles – rates and mechanisms, Chemosphere, 138 (2015) 609–615.
6. D.R. Baker, B. Kasprzyk-Hordern, Spatial and temporal occurrence of pharmaceuticals and illicit drugs in the aqueous environment and during wastewater treatment: new developments, Sci. Total Environ., 454–455 (2013) 442–456.
7. B. Petrie, R. Barden, B. Kasprzyk-Hordern, A review on emerging contaminants in wastewaters and the environment: current knowledge, understudied areas and recommendations for future monitoring, Water Res., 72 (2015) 3–27.
8. M.D. Celiz, J. Tso, D.S. Aga, Pharmaceutical metabolites in the environment: analytical challenges and ecological risks, Environ. Toxicol. Chem., 28 (2009) 2473–2484.
9. E.J. Han, D.S. Lee, Significance of metabolites in the environmental risk assessment of pharmaceuticals consumed by human, Sci. Total Environ., 592 (2017) 600–607.
10. C.G. Daughton, Pharmaceuticals and the Environment (PiE): evolution and impact of the published literature revealed by bibliometric analysis, Sci. Total Environ., 562 (2016) 391–426.
11. R. Naidu, V.A. Arias Espana, Y.J. Liu, J. Jit, Emerging contaminants in the environment: risk-based analysis for better management, Chemosphere, 154 (2016) 350–357.
12. T.A. Larsen, J. Lienert, A. Joss, H. Siegrist, How to avoid pharmaceuticals in the aquatic environment, J. Biotechnol., 113 (2004) 295–304.
13. D. White, D.J. Lapworth, W. Civil, P. Williams, Tracking changes in the occurrence and source of pharmaceuticals within the River Thames, UK; from source to sea, Environ. Pollut., 249 (2019) 257–266.
14. K. Kołecka, M. Gajewska, P. Stepnowski, M. Caban, Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology, Sci. Total Environ., 647 (2019) 149–157.
15. K. Nosek, K. Styszko-Grochowiak, J. Gołaś, Determination of acidic pharmaceuticals in municipal wastewater by using solid-phase extraction followed by gas chromatographymass spectrometry, Geomatics Environ. Eng., 6 (2012) 45, doi: 10.7494/geom.2012.6.3.45.
16. U. Kotowska, J. Kapelewska, J. Sturgulewska, Determination of phenols and pharmaceuticals in municipal wastewaters from Polish treatment plants by ultrasound-assisted emulsificationmicroextraction followed by GC-MS, Environ. Sci. Pollut. Res., 21 (2014) 660–673.
17. K. Styszko, K. Proctor, E. Castrignanò, B. Kasprzyk-Hordern, Occurrence of pharmaceutical residues, personal care products, lifestyle chemicals, illicit drugs and metabolites in wastewater and receiving surface waters of Krakow agglomeration in South Poland, Sci. Total Environ., 768 (2021) 1–18.
18. P. Paíga, L.H.M.L.M. Santos, S. Ramos, S. Jorge, J.G. Silva, C. Delerue-Matos, Presence of pharmaceuticals in the Lis river (Portugal): sources, fate and seasonal variation, Sci. Total Environ., 573 (2016) 164–177.
19. E. Carmona, V. Andreu, Y. Picó, Occurrence of acidic pharmaceuticals and personal care products in Turia River Basin: from waste to drinking water, Sci. Total Environ., 484 (2014) 53–63.
20. M. Caban, E. Lis, J. Kumirska, P. Stepnowski, Determination of pharmaceutical residues in drinking water in Poland using a new SPE-GC-MS(SIM) method based on Speedisk extraction disks and DIMETRIS derivatization, Sci. Total Environ., 538 (2015) 402–411.
21. J. Rossmann, S. Schubert, R. Gurke, R. Oertel, W. Kirch, Simultaneous determination of most prescribed antibiotics in multiple urban wastewater by SPE-LC-MS/MS, J. Chromatogr. B, 969 (2014) 162–170.
22. O. Golovko, V. Kumar, G. Fedorova, T. Randak, R. Grabic, Seasonal changes in antibiotics, antidepressants/psychiatric drugs, antihistamines and lipid regulators in a wastewater treatment plant, Chemosphere, 111 (2014) 418–426.
23. H. Zhang, Y. Zhou, Y. Huang, L. Wu, X. Liu, Y. Luo, Residues and risks of veterinary antibiotics in protected vegetable soils following application of different manures, Chemosphere, 152 (2016) 229–237.
24. P. Verlicchi, E. Zambello, Pharmaceuticals and personal care products in untreated and treated sewage sludge: occurrence and environmental risk in the case of application on soil – a critical review, Sci. Total Environ., 538 (2015) 750–767.
25. K. Styszko, K. Nosek, M. Motak, K. Bester, Preliminary selection of clay minerals for the removal of pharmaceuticals, bisphenol A and triclosan in acidic and neutral aqueous solutions, C.R. Chim., 18 (2015) 1134–1142.
26. J.C. Durán-Álvarez, B. Prado, A. Ferroud, N. Juayerk, B. Jiménez-Cisneros, Sorption, desorption and displacement of ibuprofen, estrone, and 17β estradiol in wastewater irrigated and rainfed agricultural soils, Sci. Total Environ., 473–474 (2014) 189–198.
27. M. Mezzelani, S. Gorbi, F. Regoli, Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms, Mar. Environ. Res., 140 (2018) 41–60.
28. R. de S. Pohren, J.A.V. Rocha, K.A. Leal, V.M.F. Vargas, Soil mutagenicity as a strategy to evaluate environmental and health risks in a contaminated area, Environ. Int., 44 (2012) 40–52.
29. M. Stuart, D. Lapworth, E. Crane, A. Hart, Review of risk from potential emerging contaminants in UK groundwater, Sci. Total Environ., 416 (2012) 1–21.
30. E.J. Rosi-Marshall, D. Snow, S.L. Bartelt-Hunt, A. Paspalof, J.L. Tank, A review of ecological effects and environmental fate of illicit drugs in aquatic ecosystems, J. Hazard. Mater., 282 (2015) 18–25.
31. M.S. El-Shahawi, A. Hamza, A.S. Bashammakh, W.T. Al-Saggaf, An overview on the accumulation, distribution, transformations, toxicity and analytical methods for the monitoring of persistent organic pollutants, Talanta, 80 (2010) 1587–1597.
32. A. Rivas, N. Olea, F. Olea-Serrano, Human exposure to endocrine-disrupting chemicals: assessing the total estrogenic xenobiotic burden, TrAC, Trends Anal. Chem., 16 (1997) 613–619.
33. K. Fent, A.A. Weston, D. Caminada, Ecotoxicology of human pharmaceuticals, Aquat. Toxicol., 76 (2006) 122–159.
34. P. Sathishkumar, R.A.A. Meena, T. Palanisami, V. Ashokkumar, T. Palvannan, F.L. Gu, Occurrence, interactive effects and ecological risk of diclofenac in environmental compartments and biota – a review, Sci. Total Environ., 698 (2020) 134057, doi: 10.1016/j.scitotenv.2019.134057.
35. D.J. Caldwell, F. Mastrocco, L. Margiotta-Casaluci, B.W. Brooks, An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research, Chemosphere, 115 (2014) 4–12.
36. J.C.G. Sousa, A.R. Ribeiro, M.O. Barbosa, M.F.R. Pereira, A.M.T. Silva, A review on environmental monitoring of water organic pollutants identified by EU guidelines, J. Hazard. Mater., 344 (2018) 146–162.
37. E. Archer, B. Petrie, B. Kasprzyk-Hordern, G.M. Wolfaardt, The fate of pharmaceuticals and personal care products (PPCPs), endocrine disrupting contaminants (EDCs), metabolites and illicit drugs in a WWTW and environmental waters, Chemosphere, 174 (2017) 437–446.
38. A. Hartmann, A.C. Alder, T. Koller, R.M. Widmer, Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater, Environ. Toxicol. Chem., 17 (1998) 377–382.
39. K. Vorkamp, R. Bossi, K. Bester, U.E. Bollmann, S. Boutrup, New priority substances of the European Water Framework Directive: biocides, pesticides and brominated flame retardants in the aquatic environment of Denmark, Sci. Total Environ., 470–471 (2014) 459–468.
40. Q. Sun, Y. Li, M. Li, M. Ashfaq, M. Lv, H.J. Wang, A. Hu, C.-P. Yu, PPCPs in Jiulong River estuary (China): Spatiotemporal distributions, fate, and their use as chemical markers of wastewater, Chemosphere, 150 (2016) 596–604.
41. K. Styszko, Sorption of emerging organic micropollutants onto fine sediments in a water supply dam reservoir, Poland, J. Soils Sediments, 16 (2016) 677–686.
42. N. Migowska, M. Caban, P. Stepnowski, J. Kumirska, Simultaneous analysis of non-steroidal anti-inflammatory drugs and estrogenic hormones in water and wastewater samples using gas chromatography-mass spectrometry and gas chromatography with electron capture detection, Sci. Total Environ., 441 (2012) 77–88.
43. K. Nosek, K. Styszko, J. Golas, Combined method of solid-phase extraction and GC-MS for determination of acidic, neutral, and basic emerging contaminants in wastewater (Poland), Int. J. Environ. Anal. Chem., 94 (2014) 961–974.
44. J.G.B. Ferrari, R. Mons, B. Vollat, B. Fraysse, N. Paxeus, R. Lo Giudice, A. Pollio, environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?, Environ. Toxicol. Chem., 23 (2004) 1344–1354.
45. A. Bergmann, R. Fohrmann, F.-A. Weber, U. Des, Zusammenstellung von Monitoringdaten zu Umweltkonzentrationen von Arzneimitteln (Compilation of monitoring data on environmental concentrations of pharmaceuticals), Umweltbundesamt, 66 (2011) 1–108.
46. J. Martín, M.D. Camacho-Muñoz, J.L. Santos, I. Aparicio, E. Alonso, Distribution and temporal evolution of pharmaceutically active compounds alongside sewage sludge treatment. Risk assessment of sludge application onto soils, J. Environ. Manage., 102 (2012) 18–25.
47. A. Mendoza, J.L. Rodríguez-Gil, S. González-Alonso, N. Mastroianni, M. López de Alda, D. Barceló, Y. Valcárcel, Drugs of abuse and benzodiazepines in the Madrid Region (Central Spain): seasonal variation in river waters, occurrence in tap water and potential environmental and human risk, Environ. Int., 70 (2014) 76–87.
48. K.O. K’oreje, F.J. Kandie, L. Vergeynst, M.A. Abira, H. Van Langenhove, M. Okoth, K. Demeestere, Occurrence, fate and removal of pharmaceuticals, personal care products and pesticides in wastewater stabilization ponds and receiving rivers in the Nzoia Basin, Kenya, Sci. Total Environ., 637–638 (2018) 336–348.
49. Y. Luo, W. Guo, H.H. Ngo, L.D. Nghiem, F.I. Hai, J. Zhang, S. Liang, X.C. Wang, A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment, Sci. Total Environ., 473–474 (2014) 619–641.
50. B. Kasprzyk-Hordern, A. Dabrowska, N. Vieno, L. Kronberg, J. Nawrocki, Occurrence of acidic pharmaceuticals in the Warta River in Poland, Chem. Anal. (Warsaw), 53 (2008) 289–303.
51. A. Sagan, D. Panteli, W. Borkowski, M. Dmowski, F. Domanski, M. Czyzewski, P. Gorynski, D. Karpacka, E. Kiersztyn, I. Kowalska, M. Ksiezak, K. Kuszewski, A. Lesniewska, I. Lipska, R. Maciag, J. Madowicz, A. Madra, M. Marek, A. Mokrzyck, Poland health system review, Health Syst. Transit., 13 (2011) 1–193.
52. L. Ferrando-Climent, N. Collado, G. Buttiglieri, M. Gros, I. Rodriguez-Roda, S. Rodriguez-Mozaz, D. Barceló, Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment, Sci. Total Environ., 438 (2012) 404–413.
53. H.R. Buser, T. Poiger, M.D. Müller, Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake, Environ. Sci. Technol., 32 (1998) 3449–3456.
54. S. Weigel, U. Berger, E. Jensen, R. Kallenborn, H. Thoresen, H. Hühnerfuss, Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites, Chemosphere, 56 (2004) 583–592.
55. T. Dvořáková Březinova, J. Vymazal, M. Koželuh, L. Kule, Occurrence and removal of ibuprofen and its metabolites in full-scale constructed wetlands treating municipal wastewater, Ecol. Eng., 120 (2018) 1–5.
56. D. Rozman, Z. Hrkal, M. Váňa, J. Vymazal, Z. Boukalová, Occurrence of pharmaceuticals in wastewater and their interaction with shallow aquifers: a case study of Horní Beřkovice, Czech Republic, Water, 9 (2017) 1–15.
57. D. Stülten, S. Zühlke, M. Lamshöft, M. Spiteller, Occurrence of diclofenac and selected metabolites in sewage effluents, Sci. Total Environ., 405 (2008) 310–316.
58. V. Osorio, J. Sanchís, J.L. Abad, A. Ginebreda, M. Farré, S. Pérez, D. Barceló, Investigating the formation and toxicity of nitrogen transformation products of diclofenac and sulfamethoxazole in wastewater treatment plants, J. Hazard. Mater., 309 (2016) 157–164.
59. Q. Sun, M. Lv, A. Hu, X. Yang, C.P. Yu, Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in a wastewater treatment plant in Xiamen, China, J. Hazard. Mater., 277 (2014) 69–75.
60. N.M. Vieno, H. Härkki, T. Tuhkanen, L. Kronberg, Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant, Environ. Sci. Technol., 41 (2007) 5077–5084.
61. H.J. Lee, E. Lee, S.H. Yoon, H.R. Chang, K. Kim, J.H. Kwon, Enzymatic and microbial transformation assays for the evaluation of the environmental fate of diclofenac and its metabolites, Chemosphere, 87 (2012) 969–974.
62. K.M. Onesios, J.T. Yu, E.J. Bouwer, Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review, Biodegradation, 20 (2009) 441–466.
63. S.K. Behera, H.W. Kim, J.E. Oh, H.S. Park, Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea, Sci. Total Environ., 409 (2011) 4351–4360.
64. J. Heidler, R.U. Halden, Mass balance assessment of triclosan removal during conventional sewage treatment, Chemosphere, 66 (2007) 362–369.
65. J. Heidler, A. Sapkota, R.U. Halden, Partitioning, persistence, and accumulation in digested sludge of the topical antiseptic triclocarban during wastewater treatment, Environ. Sci. Technol., 40 (2006) 3634–3639.
66. N. Nakada, T. Tanishima, H. Shinohara, K. Kiri, H. Takada, Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment, Water Res., 40 (2006) 3297–3303.
67. G. Kor-Bicakci, T. Abbott, E. Ubay-Cokgor, C. Eskicioglu, Occurrence of the persistent antimicrobial triclosan in microwave pretreated and anaerobically digested municipal sludges under various process conditions, Molecules, 25 (2020) 310, doi: 10.3390/molecules25020310.
68. C.L.G.U. Bernauer, L. Bodin, Q. Chaudhry, P.J. Coenraads, M. Dusinska, J. Ezendam, E. Gaffet, A.B. Granum, E. Panteri, V. Rogiers, C. Rousselle, M. Stepnik, T. Vanhaecke, S. Wijnhoven, W.U. Koutsodimou, A. Simonnard, Opinion on Salicylic Acid (CAS 69-72-7) Submission I, SCCS/1601/18 – Final Opin., 2018, pp. 1–70.
69. C. Potera, Caffeine in wastewater is a tracer for human fecal contamination, Environ. Health Perspect., 120 (2012) 108–109.
70. Z. Chen, P. Pavelic, P. Dillon, R. Naidu, Determination of caffeine as a tracer of sewage effluent in natural waters by on-line solid-phase extraction and liquid chromatography with diode-array detection, Water Res., 36 (2002) 4830–4838.
71. I.J. Buerge, T. Poiger, M.D. Müller, H.R. Buser, Caffeine, an anthropogenic marker for wastewater contamination of surface waters, Environ. Sci. Technol., 37 (2003) 691–700.
72. R. Loos, B.M. Gawlik, G. Locoro, E. Rimaviciute, S. Contini, G. Bidoglio, EU-wide survey of polar organic persistent pollutants in European river waters, Environ. Pollut., 157 (2009) 561–568.
73. J. Debska, A. Kot-Wasik, J. Namiesnik, Determination of nonsteroidal antiinflammatory drugs in water samples using liquid chromatography coupled with diode-array detector and mass spectrometry, J. Sep. Sci., 28 (2005) 2419–2426.
74. H.R. Buser, T. Poiger, M.D. Muller, Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater, Environ. Sci. Technol., 33 (1999) 2529–2535.
75. M. Crane, C. Watts, T. Boucard, Chronic aquatic environmental risks from exposure to human pharmaceuticals, Sci. Total Environ., 367 (2006) 23–41.
76. F. Stuer-Lauridsen, M. Birkved, L.P. Hansen, H.-C. Holten, L. Utzhùft, B. Halling-Sùrensen, environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use, Chemosphere, 40 (2000) 783–793.
77. V.L. Cunningham, S.P. Binks, M.J. Olson, Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment, Regul. Toxicol. Pharm., 53 (2009) 39–45.
78. L. Patrolecco, S. Capri, N. Ademollo, Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters, Environ. Sci. Pollut. Res., 22 (2015) 5864–5876.